"24. The Claimant, whose directors are Ms Galina Alabatchka and Mr Celestino Amore, says that it specialises in investing in illiquid securities and in recent years says it has dedicated its attention to potential Venezuelan investment opportunities, including Venezuelan government/corporate bonds and claims and other Venezuelan receivables, private equity and other Venezuelan related opportunities. 25. The First Defendant is an investment company and the Second Defendant is its Chief Investment Officer. The Fourth Defendant provides consultancy services to the First Defendant. The Third Defendant is a director of the Fourth Defendant. The First and Second Defendants say that they have specialist investment expertise relating to distressed debt and have maintained an interest in oil and petroleum companies and Venezuela for many years. 26. Between about April and November 2019 the Claimant and the Defendants discussed the possibility of a joint funding vehicle for the purpose of exploiting investment opportunities sourced by the Claimant. This was to have been a fund investing in Venezuelan investment opportunities called the Altana Illiquidx Canaima Fund ('AICF'). A promotional prospectus relating to this proposed fund was circulated from July 2019 onwards. 27. The parties entered into a non-disclosure agreement dated8 July 2019 (the 'NDA') to cover any confidential information disclosed between themselves, save that the NDA did not apply to information that was in the public domain or was already known to a party or became public other than by breach. 28. The NDA defined 'Opportunities' as 'potential Venezuela related credit investment opportunities including (but not limited to) Venezuelan government/corporate bonds and claims and other Venezuelan receivables, private equity and other such Venezuela related opportunities' and defined 'Confidential Information' as 'any and all information relating to [the First Defendant] and/or to [the Claimant] and/or any Opportunities and which is considered by the disclosing Party to be of a confidential nature (or is marked or described as confidential).' 29. The joint venture came to nothing and the parties went their separate ways in November 2019. 30. In short, the Claimant says that the Claimant disclosed confidential information to the Defendants during the period of their discussions and that the Defendants misused that information in setting up their own Atlanta Credit Opportunities Fund ('ACOF') which invests in Venezuelan government/corporate bonds and within the ACOF Presentation used to market and launch the ACOF. 31. The Defendants say that the Claimant disclosed no concrete investment opportunity or any information not already in the public domain, already known by the relevant party or published in the AICF Presentation."
"32. The key elements of the plea of breach of confidence and breach of trade secrets in the POC are as follows: (i) the Claimant has since May 2017 dedicated time and resources towards gathering intelligence and expertise in potential Venezuela related credit investment opportunities including (but not limited to) Venezuelan government/corporate bonds and claims and other Venezuelan receivables, private equity and other such Venezuela related opportunities defined as 'the Opportunities' (paragraph 6 POC); (ii) the NDA defined the 'Opportunities' as set out above ... and defined 'Confidential Information' as 'any and all information that information relating to [the First Defendant] and/or to [the Claimant] and/or any Opportunities and which is considered by the disclosing Party to be of a confidential information (or is marked or described as confidential)'. There follows an illustrative list of examples of such information (paragraph 16 POC); (iii) the express terms of the NDA on which the Claimant relies (paragraph 17 POC); (iv) the reference to Confidential Annex 1 as containing a list setting out the Confidential Information asserted by the Claimant (paragraph 19 a POC); (v) the list of 6 documents or groups of documents, the introduction of two named parties and 3 listed items of legal advice (Confidential Annex 1 to POC); (vi) the plea that the Confidential Information is a Trade Secret (paragraph 20 POC); (vii) the circumstances of confidence in which the Confidential Information was disclosed to the Defendants (paragraphs 22-25 POC); (viii) the misuse of the Confidential Information and/or Trade Secrets set out in Confidential Annex 1 and further information in Confidential Annex 6 relating to the legal framework and strategies surrounding the Opportunities in setting up ACOF, within the ACOF Presentation and by the distribution of the ACOF Presentation (paragraphs 27 and 28 POC). 33. The POC go on to claim that misuse of the Claimant's Confidential Information and/or Trade Secrets by the Defendants thereby: (i) breached the NDA; (ii) breached obligations of confidence; and (iii) unlawfully used or disclosed Trade Secrets."
"39. The proposed amendments may be grouped as follows: (i) ones dealing with the Claimant company and its history (paragraphs 1, 3, 5-5E APOC); (ii) ones relating to the preliminary discussions between the parties (paragraphs 7-8 APOC); (iii) ones relating to the Joint Venture document (paragraphs 9-10 APOC); (iv) ones relating to the Non-Disclosure and Non-Circumvention Agreement consequential on the re-arrangement of the definition of 'the Opportunities' (paragraphs 13 and 14 APOC); (v) ones relating to the NDA including the express adoption of the term 'Opportunities' in the pleading as defined in the NDA (paragraph 16 APOC): (vi) ones specifying that the confidential information relied upon is now set out in Amended Confidential Annex 1 ('ACA1') (paragraph 18, reference in paragraph19 to ACA1, and ACA1 APOC); (vii) refinements of the dates at which information is claimed to be protected in equity only or also by contract and clarification of the claim in relation to Trade Secrets (paragraphs balance of 19, 20 and 20A APOC); (viii) ones limiting the copyright claim to an earlier version of the document previously relied upon, namely one pre-dating any involvement of the Defendants (paragraphs 21 and 31 APOC); (ix) ones consequential on the proposed amendments to 19, 20 and 20A (paragraph 22 APOC); (x) ones clarifying how the dissemination of the ACOF Presentation came to the attention of the Claimant (paragraphs 27 a to c APOC) and ones pleading further information derived from the First Defendant's website about the ACOF (paragraph 27d APOC); and finally (xi) amendments to plead that the ACOF itself misuses the Confidential Information and/or Trade Secrets set out in ACA1 by misuse of the Big Idea and/or the Detail (paragraph 28 APOC) and amendments to plead that the ACOF presentation misuses the Confidential Information and/or Trade Secrets set out in ACA1 by misuse of the Big Idea and/or the Detail (paragraph 28A APOC) in the case of each paragraph by reference to the misuse set out in Amended Confidential Annex 5 ('ACA5') (original Confidential Annex 6 is no longer relied upon and ACA5 is essentially its replacement). 40. The amendments in groups apart from (vi), (viii) and (xi) are not controversial. Had they been controversial, I would have allowed those amendments as refinements and clarifications of the Claimant's case made at an early procedural stage helping better to identify issues and promote the just disposal of this case at proportionate cost. 41. The amendments in group (viii) are only opposed to the extent that details of the employment status of the three authors of the work in which the Claimant asserts copyright have not been pleaded. During the course of the hearing Mr Campbell QC offered to refine the pleading in this connection so that these details would be included. These amendments are therefore no longer controversial."
"Following the signing of the NDA, the Parties sought to progress the set-up of the Canaima Fund. The Claimant imparted confidential information to the Defendants in respect of the Opportunities (orally and/or in writing), namely that set out in Amended Confidential Annex 1 (the 'Confidential Information')."
"The Claimant provided the Defendants with a single, composite piece of confidential oral and/or written information (the 'Big Idea'), namely the fact that the Opportunities were (a) an attractive and (b) available investment proposition; in respect of which (c) the Claimant provided a recipe of application while explaining the problems that existed and the solutions for them; thereby allowing the Defendants to see the potential thereof and use the same in the ACOF Fund." iii) Paragraph 3 says "[w]ithout prejudice to the generality of the foregoing, the Big Idea satisfied each of (a), (b) and (c) for the following reasons:"
"By way of example only and without limitation, only a few explicit cross-references to the documents and/or introductions below are shown in bold." iv) Under paragraph 3 there are three main sub-paragraphs and a number of sub-sub-paragraphs. The main sub-paragraphs are headed "
"The Directors explained what bonds to look at (ISINs) in terms of bond features, such as coupon rates and maturities, as well as capital structure / credit maturity curves, given the themes of prescription and limitation, acceleration, Collective Action Clauses (CACs), cramdown, holdout, exit consent and choice of jurisdiction.
"The key factors underlying the attractiveness of the Opportunities, which included investing in Venezuelan government/corporate bonds (including PDVSA) and other Venezuelan corporates, based on Venezuela's fundamental wealth in resources and assets. The Directors explained the lack of US investors due to OFAC sanctions and the importance of sanction compliance and how to manage the relevant risks for non-US investors, including the difficulty of finding a custodian and clearing/settlement agent, who would accept the Venezuelan risk at the time." vii) There is then a section headed "
"Further or alternatively, the Claimant provided the Defendants with a great number of pieces of confidential information (which, taken together, form the single, composite, piece of confidential information identified above). Such confidential information is identified and detailed below." viii) There is then a list of documents running from a. to t., a heading "
"The ACOF Fund misuses the Confidential Information and/or Trade Secrets set out in Amended Confidential Annex 1. In particular it misuses: (a) the Big Idea; (b) further or alternatively, the Detail."
"Further or alternatively, the material in the ACOF Fund Presentation misuses and/or reproduces the Confidential Information and/or Trade Secrets set out in Amended Confidential Annex 1. In particular it misuses: a. The Big Idea; b. Further or alternatively, the Detail. (In respect of paragraphs 28 and 28A above, see Amended Confidential Annex 5 for further details)."